ALK and non-small cell lung carcinoma: <h4>Introduction</h4>ALK tyrosine kinase inhibitors (ALK TKIs) have improved prognosis in <i>ALK</i>-rearranged (<i>ALK</i> <sup>+</sup>) non-small-cell lung cancer (NSCLC).